NO20013179L - Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter - Google Patents

Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter

Info

Publication number
NO20013179L
NO20013179L NO20013179A NO20013179A NO20013179L NO 20013179 L NO20013179 L NO 20013179L NO 20013179 A NO20013179 A NO 20013179A NO 20013179 A NO20013179 A NO 20013179A NO 20013179 L NO20013179 L NO 20013179L
Authority
NO
Norway
Prior art keywords
aromatic heterocycle
hiv integrase
inhibitory activities
heterocycle compounds
integrase inhibitory
Prior art date
Application number
NO20013179A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013179D0 (no
Inventor
Toshio Fujishita
Tomokazu Yoshinaga
Akihiko Sato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20013179D0 publication Critical patent/NO20013179D0/no
Publication of NO20013179L publication Critical patent/NO20013179L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20013179A 1998-12-25 2001-06-22 Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter NO20013179L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP37127098 1998-12-25
JP24747999 1999-09-01
PCT/JP1999/007101 WO2000039086A1 (fr) 1998-12-25 1999-12-17 Composes heterocycliques aromatiques possedant des activites inhibitrices de l'integrase du vih

Publications (2)

Publication Number Publication Date
NO20013179D0 NO20013179D0 (no) 2001-06-22
NO20013179L true NO20013179L (no) 2001-08-27

Family

ID=26538287

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013179A NO20013179L (no) 1998-12-25 2001-06-22 Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter

Country Status (22)

Country Link
US (3) US6620841B1 (fr)
EP (1) EP1142872B1 (fr)
JP (1) JP3929244B2 (fr)
KR (1) KR20010089708A (fr)
CN (1) CN1178913C (fr)
AP (1) AP2001002169A0 (fr)
AT (1) ATE411286T1 (fr)
AU (1) AU763040B2 (fr)
BR (1) BR9916583A (fr)
CA (1) CA2353961A1 (fr)
CZ (1) CZ20012160A3 (fr)
DE (1) DE69939749D1 (fr)
HK (1) HK1042701A1 (fr)
HU (1) HUP0201472A3 (fr)
ID (1) ID29027A (fr)
IL (1) IL143958A0 (fr)
NO (1) NO20013179L (fr)
NZ (1) NZ512184A (fr)
PL (1) PL348596A1 (fr)
RU (1) RU2225860C2 (fr)
TR (1) TR200101886T2 (fr)
WO (1) WO2000039086A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380249B1 (en) 1998-06-03 2002-04-30 Merck & Co., Inc. HIV integrase inhibitors
US6306891B1 (en) 1998-06-03 2001-10-23 Merck & Co., Inc. HIV integrase inhibitors
US6262055B1 (en) 1998-06-03 2001-07-17 Merck & Co., Inc. HIV integrase inhibitors
JP2003525200A (ja) 1998-07-27 2003-08-26 イスティトゥト ディ リチェルケ ディ ビオロジア モレコラーレ ピー.アンジェレッティ ソチエタ ペル アツィオニ ポリメラーゼ阻害剤としてのジケト酸誘導体
GB9816358D0 (en) 1998-07-27 1998-09-23 Angeletti P Ist Richerche Bio Enzyme inhibitors
US6831177B1 (en) 1999-06-02 2004-12-14 Shionogi & Co., Ltd. Processes for the preparation of substituted propenone derivatives
CA2370500A1 (fr) * 1999-06-25 2001-01-04 Lekhanh O. Tran 1,3-propanediones-1-(aromatiques ou heteroaromatiques substitutees)-3-(heteroaromatiques substituees) et leur utilisation
AU2001262733A1 (en) * 2000-06-13 2001-12-24 Shionogi & Co., Ltd. Medicinal compositions containing propenone derivatives
WO2001095905A1 (fr) * 2000-06-14 2001-12-20 Shionogi & Co., Ltd. Inhibiteur d'enzymes possedant deux ions metal divalents en tant que centres actifs
JPWO2002038771A1 (ja) * 2000-11-09 2004-03-18 塩野義製薬株式会社 薬剤耐性hivインテグラーゼ
DK2266958T1 (da) * 2001-08-10 2016-04-04 Shionogi & Co Antiviralt middel
MXPA04003932A (es) * 2001-10-26 2004-06-18 Angeletti P Ist Richerche Bio Inhibidores de la hidroxipirimidinona carboxamida n-sustituida de la integrasa del virus de inmunodeficiencia humana.
TW200407132A (en) * 2001-11-15 2004-05-16 Shionogi & Co Process for producing 1-H-1,2,4-triazole-3-carboxylic acid ester
AU2002349675A1 (en) * 2001-12-05 2003-06-17 Shionogi And Co., Ltd. Derivative having hiv integrase inhibitory activity
US7358249B2 (en) 2002-08-13 2008-04-15 Shionogi & Co., Ltd. Heterocyclic compounds having inhibitory activity against HIV integrase
WO2004035577A2 (fr) 2002-10-16 2004-04-29 Gilead Sciences, Inc. Composes tricycliques pre-organises inhibiteurs d'integrase
CN1569803B (zh) * 2003-07-16 2011-04-13 中国科学院上海药物研究所 芳基β-二酮酸的新制备方法
EP1715855A4 (fr) * 2004-01-29 2010-06-16 Elixir Pharmaceuticals Inc Medicaments antiviraux
BRPI0514630B8 (pt) * 2004-08-25 2021-05-25 Ardea Biosciences Inc compostos de alfa-mercaptoacetanilidas de s-triazolila e composições farmacêuticas
JP4953297B2 (ja) * 2004-09-15 2012-06-13 塩野義製薬株式会社 Hivインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体
CN101068533B (zh) * 2004-12-03 2011-04-27 默沙东公司 含有抗成核剂的药物组合物
UA87884C2 (uk) * 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
US7250421B2 (en) * 2005-01-31 2007-07-31 University Of Georgia Research Foundation, Inc. Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
CA2610029A1 (fr) * 2005-06-01 2006-12-07 Bioalliance Pharma Combinaisons synergiques comprenant un compose de styrylquinoleine et d'autres agents therapeutiques contre une infection au vih
EP2066670A2 (fr) 2006-05-16 2009-06-10 Gilead Sciences, Inc. Inhibiteurs d'intégrase
EP2046328A4 (fr) 2006-07-19 2009-10-28 Univ Georgia Res Found Dicétoacides de pyridinone : inhibiteurs de la réplication du vih dans une thérapie combinée
WO2008041882A1 (fr) * 2006-10-03 2008-04-10 Viktor Veniaminovich Tets Procédé pour agir sur les virus au moyen d'une substance à base de 2,8-dithioxo-1h- pyrano[2,3-d;6,5-d'] dipyrimidine et de leurs analogues 10-aza (et variantes)
CA2713105C (fr) 2008-01-25 2016-06-07 Chimerix, Inc. Methodes de traitement d'infections virales
WO2010047774A2 (fr) * 2008-10-20 2010-04-29 The Texas A & M University System Inhibiteurs de la mycobacterium tuberculosis malate synthase, procédés de marquage et utilisations de ceux-ci
KR20120094098A (ko) 2009-12-07 2012-08-23 유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 피리디논 하이드록시사이클로펜틸 카복사미드: 치료 용도의 hiv 인테그라제 억제제
ES2629165T3 (es) 2010-02-12 2017-08-07 Chimerix, Inc. Métodos de tratamiento de una infección vírica
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
CN101928258B (zh) * 2010-08-18 2014-10-29 杭州民生药业有限公司 1-(2-取代苯胺基-4-甲基-噻唑-5)-3-取代苯基-丙烯酮衍生物、制备方法及其制药用途
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
WO2014026033A1 (fr) * 2012-08-08 2014-02-13 University Of Florida Research Foundation, Inc. Epitopes de lymphocytes t à réactivité croisée du vih, du vis et du vif pour des vaccins destinés à des humains et à des chats
SG11201504857SA (en) 2012-12-21 2015-07-30 Gilead Sciences Inc Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
NO2865735T3 (fr) 2013-07-12 2018-07-21
CA2916993C (fr) 2013-07-12 2019-01-15 Gilead Sciences, Inc. Composes polycycliques-carbomoylpyridone et leur utilisation pharmaceutique
NO2717902T3 (fr) 2014-06-20 2018-06-23
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
PL3277691T3 (pl) 2015-04-02 2019-07-31 Gilead Sciences, Inc. Policykliczne związki karbamoilopirydonowe i ich zastosowanie farmaceutyczne
CN106905244B (zh) * 2017-02-27 2019-08-16 武汉工程大学 二芳基嘧啶-二酮酸类杂合型hiv-1抑制剂及其制备方法
CN114829357A (zh) * 2019-10-28 2022-07-29 中国科学院上海药物研究所 五元杂环氧代羧酸类化合物及其医药用途
CN111943899B (zh) * 2020-09-08 2023-04-21 河北凯诺中星科技有限公司 一种5-甲酸乙酯四氮唑的合成方法
CN113683574B (zh) * 2021-09-06 2023-11-17 上海晋鲁医药科技有限公司 一种合成1-甲基-1h-1,2,4-三唑-3-甲酸甲酯的方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899508A (en) 1974-04-12 1975-08-12 Lilly Co Eli 5-(2-Aminophenyl)pyrazole-3-carboxylic acids and esters thereof
US3931247A (en) * 1974-12-11 1976-01-06 Morton-Norwich Products, Inc. 5-(Substituted)phenylfurfuryl alcohols
JPS5811878B2 (ja) * 1974-12-19 1983-03-04 大正製薬株式会社 フロ ( 3 2−b ) インド−ルルイノ セイホウ
JPS56100784A (en) 1980-01-16 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Indolizine derivative
US4273776A (en) * 1980-01-30 1981-06-16 E. R. Squibb & Sons, Inc. Antibacterial and antifungal derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones
US4336397A (en) 1980-12-29 1982-06-22 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis
US4423063A (en) 1980-12-29 1983-12-27 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis
US4332735A (en) * 1981-07-06 1982-06-01 Morton-Norwich Products, Inc. Antifungal compound
US4637829A (en) * 1984-04-27 1987-01-20 Ciba-Geigy Corporation Sulfonylureas
JPS61134346A (ja) 1984-12-03 1986-06-21 Shionogi & Co Ltd 4−オキソカルボン酸誘導体および抗潰瘍剤
CA1334975C (fr) * 1987-11-13 1995-03-28 James H. Holms Composes inhibiteurs de type lipoxygenase contenant des groupes furane et pyrrole
JPH0238403A (ja) 1988-07-28 1990-02-07 Canon Inc 光重合性組成物および記録媒体
PH27357A (en) 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
TW224974B (fr) 1991-07-02 1994-06-11 Hoffmann La Roche
EP0658559A1 (fr) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Dérivés thiénothianine, procédé pour leur préparation et leur application comme inhibiteurs de 5-dipoxygenase et cyclooxygenase
US5475109A (en) 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
ID22781A (id) 1997-04-04 1999-12-09 Pfizer Prod Inc Turunan-turunan nikotinamida
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
ID26031A (id) 1998-03-26 2000-11-16 Shionogi & Co Turunan indol yang memiliki suatu aktivitas antiviral
EP1063888A1 (fr) 1998-03-27 2001-01-03 The Regents of the University of California Nouveaux inhibiteurs de vih integrase et traitement du vih fonde sur des combinaisons de medicaments contenant des inhibiteurs d'integrase
JP2002517390A (ja) 1998-06-03 2002-06-18 メルク エンド カムパニー インコーポレーテッド Hivインテグラーゼ阻害薬
AU756826C (en) * 1998-06-03 2003-08-21 Merck & Co., Inc. HIV integrase inhibitors
EP1082121A4 (fr) 1998-06-03 2003-02-05 Merck & Co Inc Inhibiteurs de vih integrase
CA2370500A1 (fr) 1999-06-25 2001-01-04 Lekhanh O. Tran 1,3-propanediones-1-(aromatiques ou heteroaromatiques substitutees)-3-(heteroaromatiques substituees) et leur utilisation

Also Published As

Publication number Publication date
US20040002485A1 (en) 2004-01-01
RU2001120016A (ru) 2003-12-10
AU1797900A (en) 2000-07-31
EP1142872A4 (fr) 2002-04-17
TR200101886T2 (tr) 2001-12-21
CA2353961A1 (fr) 2000-07-06
DE69939749D1 (de) 2008-11-27
EP1142872A1 (fr) 2001-10-10
JP3929244B2 (ja) 2007-06-13
PL348596A1 (en) 2002-06-03
NO20013179D0 (no) 2001-06-22
US6620841B1 (en) 2003-09-16
ID29027A (id) 2001-07-26
HK1042701A1 (zh) 2002-08-23
ATE411286T1 (de) 2008-10-15
US7098201B2 (en) 2006-08-29
CZ20012160A3 (cs) 2001-10-17
IL143958A0 (en) 2002-04-21
HUP0201472A2 (hu) 2003-10-28
RU2225860C2 (ru) 2004-03-20
HUP0201472A3 (en) 2006-03-28
CN1178913C (zh) 2004-12-08
NZ512184A (en) 2003-08-29
BR9916583A (pt) 2001-09-25
WO2000039086A1 (fr) 2000-07-06
US6645956B1 (en) 2003-11-11
AP2001002169A0 (en) 2001-06-30
EP1142872B1 (fr) 2008-10-15
KR20010089708A (ko) 2001-10-08
CN1335834A (zh) 2002-02-13
AU763040B2 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
NO20013179D0 (no) Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter
NO20042673L (no) Acetylenderivaer som har mGluR5 antagonistisk aktivitet
DK1104420T3 (da) Substituerede 1,8-naphthyridin-4(1H)-oner som phosphodiesterase-4-inhibitorer
AU2003257822A1 (en) Heterocyclic compound having hiv integrase inhibitory activity
NO20015078D0 (no) Sulfonamidderivater som har oksadiazolringer
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
NO20032926L (no) Heterocykliske forbindelser som har antibakteriell aktivitet, fremgangsmåtefor deres fremstilling og farmasöytiske sammensetninger sominneholder dem
NO20011738D0 (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
DK0882024T3 (da) Forbindelser, som inhiberer retroviral protease
DK1222192T3 (da) Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor
NO20030153L (no) Blandinger som inneholder terapeutisk aktive komponenter som har foröket löselighet
BR9915552B1 (pt) Pirimidinas inibidoras da reprodução do hiv
DK0945443T3 (da) HIV-hæmmende pyrimidinderivater
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
AU2001295310A1 (en) Aromatic derivatives with hiv integrase inhibitory properties
DE69906981D1 (de) Herbizide phenoxypropionsäure-n-alkyl-n-2-fluorophenylamid-verbindungen
NO20030100L (no) Pleuromutilinderivater som har antibakteriell aktivitet
NO20025635L (no) Anvendelse av biguanidderivater til fremstilling av et legemiddel som har en sarhelende virkning
AU2002349675A1 (en) Derivative having hiv integrase inhibitory activity
NO20013441D0 (no) Sammensetninger som har forbedret stabilitet
NO20020485L (no) Heterocykliske forbindelser som inhiberer angiogenese
NO972914D0 (no) Substituerte tiadiazoler, blandinger inneholdende dem og deres anvendelse som antimikrobielle og marine antibegroingsmidler
NO20041295L (no) Tieno(1,3)oksazin-4-oner med lipaseinhiberende aktivitet
IT1308147B1 (it) Elemento attivo per tamburi fresanti dimacchine operatrici per la rimozione di suoli, provvisto di
PT1192154E (pt) Compostos de bispidina uteis para o tratamento de arritmias cardiacas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application